Literature DB >> 23358397

Hepatitis: Long-term therapy of chronic hepatitis B reverses cirrhosis.

Anna Suk-Fong Lok.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23358397     DOI： 10.1038/nrgastro.2013.13

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.

Authors:  Ludivine Falize; Anne Guillygomarc'h; Michele Perrin; Fabrice Lainé; Dominique Guyader; Pierre Brissot; Bruno Turlin; Yves Deugnier
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

Review 2.  Clinical evidence for the regression of liver fibrosis.

Authors:  Elizabeth L Ellis; Derek A Mann
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

3.  Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

Authors:  Ting-Tsung Chang; Yun-Fan Liaw; Shun-Sheng Wu; Eugene Schiff; Kwang-Hyub Han; Ching-Lung Lai; Rifaat Safadi; Samuel S Lee; Waldemar Halota; Zachary Goodman; Yun-Chan Chi; Hui Zhang; Robert Hindes; Uchenna Iloeje; Suzanne Beebe; Bruce Kreter
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Authors:  Patrick Marcellin; Edward Gane; Maria Buti; Nezam Afdhal; William Sievert; Ira M Jacobson; Mary Kay Washington; George Germanidis; John F Flaherty; Raul Aguilar Schall; Jeffrey D Bornstein; Kathryn M Kitrinos; G Mani Subramanian; John G McHutchison; E Jenny Heathcote
Journal:  Lancet       Date:  2012-12-10       Impact factor: 79.321

5.  Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B.

Authors:  Mario Rizzetto; Nicholas C Tassopoulos; Robert D Goldin; Rafael Esteban; Teresa Santantonio; E Jenny Heathcote; Marco Lagget; Namrata K Taak; Mary A Woessner; Stephen D Gardner
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

6.  Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

Authors:  Stephanos J Hadziyannis; Nicolaos C Tassopoulos; E Jenny Heathcote; Ting-Tsung Chang; George Kitis; Mario Rizzetto; Patrick Marcellin; Seng Gee Lim; Zachary Goodman; Jia Ma; Carol L Brosgart; Katyna Borroto-Esoda; Sarah Arterburn; Steven L Chuck
Journal:  Gastroenterology       Date:  2006-09-20       Impact factor: 22.682

7.  Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Authors:  Sarah Maylin; Michelle Martinot-Peignoux; Rami Moucari; Nathalie Boyer; Marie-Pierre Ripault; Dominique Cazals-Hatem; Nathalie Giuily; Corinne Castelnau; Ana Carolina Cardoso; Tarik Asselah; Cyrille Féray; Marie Hélène Nicolas-Chanoine; Pierre Bedossa; Patrick Marcellin
Journal:  Gastroenterology       Date:  2008-05-21       Impact factor: 22.682

8.  Histological outcome during long-term lamivudine therapy.

Authors:  Jules L Dienstag; Robert D Goldin; E Jenny Heathcote; H W L Hann; Mary Woessner; Sally L Stephenson; Stephen Gardner; D Fraser Gray; Eugene R Schiff
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

9.  Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.

Authors:  John B Dixon; Prithi S Bhathal; Norman R Hughes; Paul E O'Brien
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425
  9 in total
  19 in total

1.  [Antiviral and antifibrotic therapies reduce occurrence of hepatocellular carcinoma in patients with chronic hepatitis B and liver fibrosis: a 144-week prospective cohort study].

Authors:  Yuchen Zhou; Chengguang Hu; Guosheng Yuan; Junwei Liu; Yanyu Ren; Cuirong Tang; Shuling Yang; Lin Dai; Yuan Li; Dinghua Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

2.  Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP/TAZ signaling.

Authors:  Wen Zhao; Xiaoxiao Zhang; Mengmeng Hou; Yuguo Zhang; Yuhui Tang; Lu Li; Shiming Dong; Lingdi Liu; Dandan Zhao; Wencong Li; Yuemin Nan
Journal:  Histol Histopathol       Date:  2021-09-07       Impact factor: 2.303

3.  Ectopic expression of micro-RNA-1, 21 and 125a in peripheral blood immune cells is associated with chronic HBV infection.

Authors:  Mohammad Momeni; Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Mol Biol Rep       Date:  2014-04-16       Impact factor: 2.316

Review 4.  Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection.

Authors:  Lu Lun-Gen
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

Review 5.  Antiviral therapy for chronic hepatitis B in China.

Authors:  Xin Zheng; Junzhong Wang; Dongliang Yang
Journal:  Med Microbiol Immunol       Date:  2014-12-25       Impact factor: 3.402

Review 6.  Current strategies for quantitating fibrosis in liver biopsy.

Authors:  Yan Wang; Jin-Lin Hou
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

7.  Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations.

Authors:  Chuoji Huang; Hui Heng Lin; Jian-Bo Wan; Chengwei He; Yuanjia Hu
Journal:  PLoS One       Date:  2016-10-11       Impact factor: 3.240

8.  Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccination.

Authors:  Anette Brass; Lars Frelin; David R Milich; Matti Sällberg; Gustaf Ahlén
Journal:  Mol Ther       Date:  2014-12-10       Impact factor: 11.454

9.  Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings.

Authors:  Calvin Q Pan; Huy Trinh; Alan Yao; Ho Bae; Lillian Lou; Sing Chan
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

10.  A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.

Authors:  Thomas H King; Charles B Kemmler; Zhimin Guo; Derrick Mann; Yingnian Lu; Claire Coeshott; Adam J Gehring; Antonio Bertoletti; Zi Z Ho; William Delaney; Anuj Gaggar; G Mani Subramanian; John G McHutchison; Shikha Shrivastava; Yu-Jin L Lee; Shyamasundaran Kottilil; Donald Bellgrau; Timothy Rodell; David Apelian
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.